What Challenges Exist in Using Nanotechnology for Biomarker Detection?
Despite the promising potential, there are several challenges:
Toxicity: The safety and biocompatibility of nanomaterials need thorough evaluation. Standardization: Lack of standardized protocols for the synthesis and characterization of nanomaterials. Regulatory Hurdles: Stringent regulatory requirements for the approval of nanotechnological products in clinical settings. Cost: High production costs can limit widespread adoption.
